Mounting patent losses, efforts to curb healthcare spending and an increase in age and lifestyle-related diseases are leading to a surge in the demand for generic drugs.
CPhI Worldwide and FDF have published a free industry report which delves into these topics as well as others such as competition and consolidation, healthcare spending, regulatory changes and many more!